Search For "covaxin"
Bharat Biotech says EUL for COVAXIN submitted to WHO, approval expected by
Updated : 4 years, 10 months ago IST
New Delhi [India], May 26 (ANI): COVID-19 vaccine COVAXIN's manufacturer Bharat Biotech on Tuesday said application for Emergency Use Listing (EUL) of its vaccine has been submitted to World Health Organisation (WHO), Geneva, and regulatory approvals are expected between July and Septembe
Read More
No Covaxin left for 45-plus age group in Delhi: AAP MLA Atishi
Updated : 4 years, 10 months ago IST
New Delhi [India], May 25 (ANI): There is no stock of Covaxin for the vaccination of above 45 years age group against COVID-19 in the national capital, informed Aam Aadmi Party (AAP) MLA Atishi on Tuesday
Read More
Facing Covaxin shortfall, Karnataka to give 2nd dose only to those above 4
Updated : 4 years, 10 months ago IST
Bengaluru (Karnataka) [India], May 25 (ANI): The Karnataka government, in order to tide over a shortfall in Covaxin stock in the state, has directed health officials to administer the second dose of Covid-19 vaccine only to people aged above 45 years.
Read More
Bharat Biotech submits 90 pc documentation, confident of WHO emergency use
Updated : 4 years, 10 months ago IST
New Delhi [India], May 24 (ANI): Bharat Biotech is confident about obtaining the World Health Organization's (WHO) Emergency Use Listing for its COVID-19 vaccine given its experience of getting its other vaccines pre-qualified and has submitted 90 per cent of the documentation required for E
Read More
Paediatric trials of Covaxin may begin in June
Updated : 4 years, 10 months ago IST
Hyderabad (Telangana) [India], May 24 (ANI): Bharat Biotech may begin paediatric trials of its Covid-19 vaccine Covaxin from June, said the company's Business Development and International Advocacy Head Dr Raches Ella on Sunday.
Read More
Bharat Biotech to scale up Covaxin production, eyes 200 mn doses annually
Updated : 4 years, 10 months ago IST
New Delhi [India], May 20 (ANI): Amid the growing demand for vaccines in the country, Hyderabad-based Bharat Biotech has announced ramping up of additional manufacturing capacities for Covaxin at Chiron Behring Vaccines in Gujarat's Ankleshwar.
Read More
Delhi HC refuses to put stay on Phase 2-3 clinical trials of Covaxin for 2
Updated : 4 years, 10 months ago IST
New Delhi [India], May 19 (ANI): The Delhi High Court on Wednesday refused to put an interim stay on Phase 2-3 clinical trials of Covaxin COVID-19 vaccine for the 2-18 age group.
Read More
Quash notification allowing phase 2/3 trials of Covaxin in 2-18 years age
Updated : 4 years, 10 months ago IST
New Delhi [India], May 18 (ANI): A Public Interest Litigation (PIL) has been moved in Delhi High Court seeking quashing of Centre's "notification" of May 13, which has accorded permission for conduct of phase two/three clinical trials of Covaxin in the age group 2 to 18 years to its manuf
Read More
Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12
Updated : 4 years, 10 months ago IST
New Delhi [India], May 18 (ANI): Bharat Biotech is set to begin the phase II and III clinical trials for COVID-19 vaccine Covaxin in children in the age group of 2 to 18 years in the next 10-12 days, informed VK Paul, Member (Health), Niti Aayog on Tuesday.
Read More
COVID-19: Delhi left with 1 day Covaxin stock for people aged 45 and above
Updated : 4 years, 10 months ago IST
New Delhi [India], May 16 (ANI): Delhi has only one day of COVID-19 vaccine Covaxin sock left for beneficiaries aged 45 years and above, while Covishield stock will last for five days for the same group of beneficiaries, Aam Aadmi Party (AAP) MLA Atishi Marlena informed on Sunday.
Read More
Bengaluru residents face difficulties in securing COVAXIN doses
Updated : 4 years, 10 months ago IST
Bengaluru (Karnataka) [India], May 16 (ANI): Amid the rising COVID-19 cases in Karnataka, locals in Bengaluru say that they have been facing a lot of difficulties in getting the COVAXIN vaccine.
Read More
COVAXIN effective against coronavirus strains found in India, UK
Updated : 4 years, 10 months ago IST
New Delhi [India], May 16 (ANI): Vaccination with Bharat Biotech's COVID-19 vaccine - COVAXIN, has produced neutralising titres (concentration) against all key emerging variants tested, including the B.1.617 and B.1.1.7, first identified in India and the United Kingdom, the vaccine manufa
Read More